Delivery Order SPE2DB20D1004-SPE2DB23FF8W5
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $7,798.56 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Eliquis 5 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical worth up to $999,999,999.00, which runs through November 2026. The IDC serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $10,041.31 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Eliquis 5 mg tablets and has an ultimate completion date of January 21, 2022. This award is under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC enables the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $8,648.88 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Eliquis 5 mg tablets. This contract, with a completion date of January 11, 2024, is a firm-fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. The IDC serves as the primary vehicle for Cencora, Inc. to provide a...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Eliquis 5 mg tablets. The $19,101.27 firm-fixed-price contract has an ultimate completion date of August 16, 2021. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,739.53 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Eliquis 5 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,586.62 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $92,341.33 to Amerisourcebergen Drug Corp, a division of the pharmaceutical distribution company Cencora, Inc. The contract is for the supply of 4,559,490,389 units of the prescription medication Eliquis 5 mg tablets. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 through December 2025,...
- The Defense Logistics Agency (DLA) awarded a $8,626.47 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Eliquis 5 mg tablets. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract...
- This federal contract award is between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Cencora, Inc. The contract, valued at $14,345.72, is for the delivery of Eliquis 5 mg tablets to support military treatment facilities and federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support Medical, which serves as...
- The U.S. government has awarded a delivery order contract worth $6,279.72 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Eliquis 5 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of pharmaceutical products and medical supplies to the Department of Defense (DoD) and other federal agencies. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc....
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB23FF8W5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $15,595.23 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 60-count bottles of Eliquis 5 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. Cencora, Inc. also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.6k | 5/15/23 |